High-throughput cell-based assays in yeast

Drug Discovery Today

Volumn 7, Issue 18, 2002, Pages

  Tucker, Chandra L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN;

ANALYTIC METHOD; CELL ASSAY; CELL FUNCTION; GENETIC RECOMBINATION; GENOME ANALYSIS; GENOMICS; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN RNA BINDING; REVIEW; SACCHAROMYCES CEREVISIAE; TWO HYBRID SYSTEM;

BIOLOGICAL ASSAY; DRUG EVALUATION, PRECLINICAL; NUCLEIC ACID HYBRIDIZATION; PHARMACOLOGY; PROTEINS; SACCHAROMYCES CEREVISIAE; YEASTS;

EID: 0037107026     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02409-1     Document Type: Review

References (44)

1. DeRisi J.L., et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 278:1997;680-686.
2. Gavin A.C., et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141-147.
3. Ho Y., et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 415:2002;180-183.
4. Uetz P., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:2000;623-627.
5. Ito T., et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4569-4574.
6. Zhu H., et al. Global analysis of protein activities using proteome chips. Science. 293:2001;2101-2105.
7. Tong A.H., et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 294:2001;2364-2368.
8. Winzeler E.A., et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 285:1999;901-906.
9. Mumberg D., et al. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene. 156:1995;119-122.
10. Ma H., et al. Plasmid construction by homologous recombination in yeast. Gene. 58:1987;201-216.
11. Kolaczkowski M., et al. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microb. Drug Resist. 4:1998;143-158.
12. Kaur R., Bachhawat A.K. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiology. 145:1999;809-818.
13. Bard M., et al. Differences in crystal violet uptake and cation-induced death among yeast sterol mutants. J. Bacteriol. 135:1978;1146-1148.
14. Parks L.W., et al. Biochemical and physiological effects of sterol alterations in yeast - a review. Lipids. 30:1995;227-230.
15. Mahe Y., et al. The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J. Biol. Chem. 271:1996;25167-25172.
16. Fields S., Song O-K. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
17. Phizicky E.M., Fields S. Protein-protein interactions: methods for detection and analysis. Microbiol. Rev. 59:1999;94-123.
18. Vidal M., Legrain P. Yeast forward and reverse 'n'-hybrid systems. Nucleic Acids Res. 27:1999;919-929.
19. Bartel P., et al. Elimination of false positives that arise in using the two-hybrid system. BioTechniques. 14:1993;920-924.
20. Durfee T., et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:1993;555-569.
21. Gyuris J., et al. Cdi, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 75:1993;791-803.
22. Bendixen C., et al. A yeast mating-selection scheme for detection of protein-protein interactions. Nucleic Acids Res. 22:1994;1778-1779.
23. Finley R.L., Brent R. Interaction mating reveals binary and ternary connections between drosophila cell cycle regulators. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12980-12984.
24. Bartel P.L., et al. A protein linkage map of Escherichia coli bacteriophage T7. Nat. Genet. 12:1996;72-77.
25. Fromont-Racine, et al. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16:1997;277-282.
26. McCraith S., et al. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4879-4884.
27. SenGupta D.J. A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8496-8501.
28. Licitra E.J., Liu J.O. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12817-12821.
29. Vidal M. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 19:1996;10315-10320.
30. Huang J., Schreiber S.L. A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proc. Natl. Acad. Sci. U. S. A. 94:1997;13396-13401.
31. Johnsson N., Varshavsky A. Split ubiquitin as a sensor of protein interactions in vivo. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10340-10344.
32. Stagljar I., et al. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5187-5192.
33. Aronheim A., et al. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell Biol. 17:1997;3094-3102.
34. Metzger D., et al. The human oestrogen receptor functions in yeast. Nature. 334:1988;31-36.
35. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Env. Toxicol. Chem. 15:1996;241-248.
36. Tucker C.L., Fields S. A yeast sensor of ligand binding. Nat. Biotech. 19:2001;1042-1046.
37. Tugendreich S., et al. A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays. Genome Res. 11:2001;1899-1912.
38. Pauch M.H. G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery. Trends Biotechnol. 15:1997;487-494.
39. Cismowski M.J., et al. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nat. Biotech. 17:1999;878-883.
40. Sibley C.H., et al. Yeast as a model system to study drugs effective against apicomplexan proteins. Methods. 13:1997;190-207.
41. Wooden J.M., et al. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol. Biochem. Parasitol. 85:1997;25-40.
42. Brophy V.H., et al. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 44:2000;1019-1028.
43. Nitiss J.L., et al. Using yeast to understand drugs that target topoisomerases. Ann. N. Y. Acad. Sci. 803:1996;32-43.
44. Hammonds T.R., et al. Use of a rapid throughput in vivo screen to investigate inhibitors of eukaryotic topoisomerase II enzymes. Antimicrob. Agents Chemother. 42:1998;889-894.